Latest Corporate News
BioMarin Announces $4.8 Billion Acquisition of Amicus Therapeutics
BioMarin is acquiring Amicus Therapeutics in an all-cash $4.8 billion deal financed by cash reserves and $3.7 billion in new debt, with bridge financing from Morgan Stanley. The acquisition is expected to be accretive to Non-GAAP Diluted EPS within the first 12 months and substantially so from 2027, leveraging Amicus's Galafold and Pombiliti products that generated $599 million last year.
Closure is targeted for Q2 2026 pending regulatory approvals and shareholder vote.
Marelli Automotive Supplier Files Chapter 11 Bankruptcy
Marelli, a KKR-owned auto parts giant with $11.5 billion in acquisitions, filed Chapter 11 with $4.9 billion debt due to COVID, tariffs, and EV market volatility. DIP lenders will own 100% of the reorganized company upon 2026 emergence.
The restructuring follows KKR's 2016-2019 roll-up of Calsonic Kansei ($4.5B) and Magneti Marelli ($7.2B).
Chinese AI Firms Zhipu and MiniMax Rush IPOs Amid Cash Burn
Zhipu AI and MiniMax filed dual IPOs after rapid growth but brutal cash burns: Zhipu at ¥300M monthly, MiniMax at ¥2B monthly, with reserves depleting fast. Zhipu revenue grew 130% CAGR to ¥312M in 2024; MiniMax surged 782% to $30.5M, already exceeding in 2025 H1.
Strategies differ: Zhipu scales frontier models with heavy R&D; MiniMax emphasizes capital efficiency vs. OpenAI's $40-55B spend.
Global Corporate Earnings Calendar Empty on January 4
No major S&P 500, Euro Stoxx 50, Nikkei 225, or MOEX companies report results today, a Sunday pause before Q4 2025 season starts mid-January. US banks and tech giants like Microsoft (strong cloud growth) and Walmart (high sales) exceeded Q3 expectations.
Europe eyes Q4 mixed results: bank profits up, industrials hit by energy costs; full-year reports in February.
Leapfrog Acquisition Corporation Lock-Up Expires Today
435,000 units of Leapfrog Acquisition Corp end 31-day lock-up on January 4, 2026, from December 4 start. Founder shares restricted until one year post-business combination or liquidation, with exceptions for price thresholds over $12/share.
Private placement securities also locked until 30 days post-combination.